Ünsal H, et al. A large single-center cohort of bare lymphocyte syndrome: immunological and genetic features in Turkey. Scand J Immunol. 2024;99(1):e13335.

Article  PubMed  Google Scholar 

Wieczorek M, et al. Major histocompatibility complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation. Front Immunol. 2017;8:292.

Article  PubMed  PubMed Central  Google Scholar 

Reith W, Mach B. The bare lymphocyte syndrome and the regulation of MHC expression. Annu Rev Immunol. 2001;19:331–73.

Article  PubMed  CAS  Google Scholar 

Staehli F, et al. NLRC5 deficiency selectively impairs MHC class I-dependent lymphocyte killing by cytotoxic T cells. J Immunol. 2012;188(8):3820–8.

Article  PubMed  CAS  Google Scholar 

Schubach M, et al. CADD v1.7: using protein language models, regulatory CNNs and other nucleotide-level scores to improve genome-wide variant predictions. Nucleic Acids Res. 2024;52(D1):D1143–54.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Meng E, et al. UCSF ChimeraX: tools for structure building and analysis. Protein Sci. 2023;32(11):e4792.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cheng J, et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science. 2023;381(6664):1303.

Article  Google Scholar 

Chen Y, et al. PremPS: predicting the impact of missense mutations on protein stability. PLOS Comput Biol. 2020;16(12):e1008543.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Del Conte A, et al. RING 4.0: faster residue interaction networks with novel interaction types across over 35,000 different chemical structures. Nucleic Acids Res. 2024;52(W1):W306–12.

Article  PubMed  PubMed Central  Google Scholar 

Yampolsky L, Stoltzfus A. The exchangeability of amino acids in proteins. Genetics. 2005;170(4):1459–72.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hanna S, Etzioni A. MHC class I and II deficiencies. J Allergy Clin Immunol. 2014;134(2):269–75.

Article  PubMed  CAS  Google Scholar 

Al-Herz W, et al. Major histocompatibility complex class II deficiency in Kuwait: Clinical manifestations, immunological findings and molecular profile. J Clin Immunol. 2013;33(3):513–9.

Article  PubMed  CAS  Google Scholar 

Masternak K, et al. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 2000;14(9):1156–66.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Farrokhi S, et al. MHC class II deficiency: Report of a novel mutation and special review. Allergol Immunopathol. 2018;46(3):263–75.

Article  CAS  Google Scholar 

Ludigs K, et al. NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module. PLOS Genet. 2015;11(3):e1005088.

Article  PubMed  PubMed Central  Google Scholar 

Meissner T, et al. NLRC5 cooperates with the RFX transcription factor complex to induce MHC CLass I gene expression. J Immunol. 2012;188(10):4951–8.

Article  PubMed  CAS  Google Scholar 

Neerincx A, et al. NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner. J Immunol. 2012;188(10):4940–50.

Article  PubMed  CAS  Google Scholar 

Vijayan S, et al. Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance. Immunogenetics. 2019;71(3):273–82.

Article  PubMed  CAS  Google Scholar 

Delavari S, et al. Clinical heterogeneity in families with multiple cases of inborn errors of immunity. Clin Immunol. 2024;259:109896.

Article  PubMed  CAS  Google Scholar 

Gamze S, et al. Five patients with two novel homozygous variants in CD3 subunits and comprehensive review of the literature. J Allergy Clin Immunol: Practice. Published online March 25, 2025. https://doi.org/10.1016/j.jaip.2025.03.022.